Brant Point Investment Management’s Integra LifeSciences IART Stock Holding History

Brant Point Investment Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-24,700	Closed	-$1.04M	–	137
2017 Q1	$1.04M	Buy	+24,700	New	+$1.06M	0.11%	129
2016 Q3	–	Sell	-42,800	Closed	-$1.71M	–	144
2016 Q2	$1.71M	Sell	42,800 -19,600	-31%	-$705K	0.16%	114
2016 Q1	$2.1M	Sell	62,400 -150,000	-71%	-$4.67M	0.22%	92
2015 Q4	$7.2M	Sell	212,400 -139,800	-40%	-$4.37M	0.82%	32
2015 Q3	$10.5M	Buy	+352,200	New	+$11M	1.17%	17

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brant Point Investment Management's IART Position: Q2 2017 in Review

Brant Point Investment Management sold out of Integra LifeSciences (IART) in Q2 2017, closing a stake of 24,700 shares — an estimated $1.04M sold.

Brant Point Investment Management first reported a position in IART in Q3 2015 and held it in 5 quarters. The position peaked at $10.5M in Q3 2015. 223 funds tracked by Wall St. Rank hold IART as of Q2 2017.

Brant Point Investment Management reported no remaining Integra LifeSciences position as of Q2 2017 after selling out during the quarter.
Brant Point Investment Management sold 24,700 Integra LifeSciences shares in Q2 2017, an estimated $1.04M.
Brant Point Investment Management first reported a position in Integra LifeSciences in Q3 2015 and held it in 5 quarters.
Brant Point Investment Management's Integra LifeSciences position peaked at $10.5M in Q3 2015.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2017.

Based on Brant Point Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.